Bortezomib is a rapid mobilizer of hematopoietic stem cells in mice via modulation of the VCAM-1/VLA-4 axis.
Ghobadi, Armin; Rettig, Michael P; Cooper, Matthew L; Holt, Matthew S; Ritchey, Julie K; Eissenberg, Linda; DiPersio, John F.
; 124(17): 2752-4, 2014 Oct 23.
Artigo em Inglês | MEDLINE | ID: mdl-25342668
Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13.
Lateral Mobility and Nanoscale Spatial Arrangement of Chemokine-activated α4ß1 Integrins on T Cells.
Facile synthesis and <sup>18</sup>F-radiolabeling of α<sub>4</sub>ß<sub>1</sub>-specific LLP2A-aryltrifluoroborate peptidomimetic conjugates.
Modeling the molecular basis for α4ß1 integrin antagonism.
BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
Kindlin-3 Is Essential for the Resting α4ß1 Integrin-mediated Firm Cell Adhesion under Shear Flow Conditions.
Proteomic analysis of α4ß1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.
Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progression.
How natalizumab binds and antagonizes α4 integrins.
Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor.